IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 97 filers reported holding IMMUNOVANT INC in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,436,500 | +177.0% | 350,000 | +36.9% | 0.03% | +145.5% |
| Q2 2023 | $4,850,193 | -27.3% | 255,677 | -32.0% | 0.01% | -38.9% |
| Q4 2022 | $6,670,006 | +678.3% | 375,775 | +144.8% | 0.02% | +500.0% |
| Q3 2022 | $857,000 | +958.0% | 153,503 | +950.2% | 0.00% | – |
| Q1 2022 | $81,000 | -97.1% | 14,616 | -75.6% | 0.00% | -100.0% |
| Q4 2020 | $2,770,000 | – | 59,974 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 3,007,000 | $25,620,000 | 3.77% |
| Deep Track Capital, LP | 4,775,000 | $40,683,000 | 2.87% |
| Octagon Capital Advisors LP | 572,862 | $4,881,000 | 0.95% |
| Eventide Asset Management | 4,950,000 | $42,174,000 | 0.54% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,197,000 | 0.44% |
| FRAZIER MANAGEMENT LLC | 585,759 | $4,991,000 | 0.38% |
| MANGROVE PARTNERS IM, LLC | 688,000 | $5,862,000 | 0.35% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $463,000 | 0.31% |
| EcoR1 Capital, LLC | 1,140,819 | $9,720,000 | 0.31% |
| MANGROVE PARTNERS IM, LLC | 570,400 | $4,860,000 | 0.29% |